Payers who intend to improve patient outcomes while decreasing inappropriate drug utilization in oncology care are positioned to implement clinical pathways now more than ever before.
Prior authorization is a commonly used management strategy that is effective to a certain degree, but there is still room for improvement. Payers and practitioners alike agree that the ideal management strategy should enable practitioners to take the wheel in selecting a patient’s pharmacotherapy, which prior authorization can inhibit.
Clinical pathways can help to reduce the need for prior authorization as a management strategy while satisfying oncologists’ needs. The figure “Pathways to prior authorization goals” shows how goals of prior authorization can be met by clinical pathways.
The 50% of plans across the nation that have already implemented pathways or plan to do so soon see that the greatest return on investment of clinical pathways is for cancer diagnoses that are most prevalent and/or are associated with the highest drug cost.
The figure below shows the most common tumor types for which pathways have been developed by health plans.
Tumor types that are most often addressed by clinical pathways
Proportion of payers
Source: “Payers Working Collaboratively With Providers to Adopt Clinical Pathways and New Care Delivery Models,” Journal of Oncology Practice, Vol. 9, issue 2
Our other journal
P&T Journal for September 2014
FEATURES
HEALTH CARE & LAW
Legal Risk Management Opportunities, Pharmacy Practice, and P&T Committees
Hospitals Struggle With ACA Challenges
Drug–Gene Interactions: Inherent Variability in Drug Maintenance Dose Requirements
Schizophrenia: Overview and Treatment Options
PIPELINE PLUS
Schizophrenia Therapy Options Increasing
DEPARTMENTS
MEDICATION ERRORS
Too Many Abandon the “Second Victims” of Medical Errors
PRESCRIPTION: WASHINGTON
New Controversy for 340B: OPA Rebuffs Ruling by Court
New Drugs/Drug News/New Medical Devices
Pharmaceutical Approval Update
DRUG FORECAST
Loxapine Inhalation Powder (Adasuve)
Paul Lendner ist ein praktizierender Experte im Bereich Gesundheit, Medizin und Fitness. Er schreibt bereits seit über 5 Jahren für das Managed Care Mag. Mit seinen Artikeln, die einen einzigartigen Expertenstatus nachweisen, liefert er unseren Lesern nicht nur Mehrwert, sondern auch Hilfestellung bei ihren Problemen.